Avante (XX) AGM 2024 summary
Event summary combining transcript, slides, and related documents.
AGM 2024 summary
8 Apr, 2026Opening remarks and agenda
Meeting opened virtually with emphasis on shareholder participation and voting on all business matters.
Agenda included financial statement review, auditor appointment, director elections, stock option plan approval, and shareholder proposals.
Introduction of directors and management, confirmation of quorum, and explanation of voting procedures.
Financial performance review
Audited consolidated financial statements for fiscal years ended March 31, 2024 and 2023, and unaudited interim statements for Q1 2025 presented.
Q1 2025 revenues were CAD 7.9 million, adjusted EBITDA CAD 363,000, cash in bank CAD 6.2 million, and undrawn credit line of CAD 12 million.
Operational improvements led to positive cash flow and a strong financial position.
Board and executive committee updates
Five management nominees and three shareholder nominees were presented for five board positions.
Management nominees elected: Dan Argiros, Wade Burton, Rob Klopot, Emmanuel Mounouchos, and Bruce Bronfman.
Key management team and board members introduced, highlighting experience and roles.
Latest events from Avante
- Advanced security technology and acquisitions drive strong growth and global expansion.XX
Investor presentation22 Apr 2026 - All agenda items, including board elections and stock plan approval, passed by majority vote.XX
AGM 20258 Apr 2026 - AI-powered security solutions and recurring revenue drive robust growth and global expansion.XX
Investor presentation4 Mar 2026 - Q3 2026 delivered strong revenue and profit growth, with robust recurring revenues and segment gains.XX
Q3 20263 Mar 2026 - 46% revenue growth and recurring revenue gains highlight robust Q1 performance.XX
Q1 202523 Jan 2026 - Q2 revenue up 52% year-over-year, with strong recurring growth and new AI security launches.XX
Q2 202512 Jan 2026 - Record Q3 revenue and EBITDA growth fueled by recurring revenue and innovation, with strong outlook.XX
Q3 202526 Dec 2025 - Q2 2026 saw 10% revenue growth, 73% higher EBITDA, and a strong debt-free position.XX
Q2 20261 Dec 2025 - Revenue up 11%, recurring revenue up 25%, NSSG up 126%, and net income positive.XX
Q1 202623 Nov 2025